Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
JAMA
|
November 3, 2001
A 52-year-old man with a positive PPD
M Iseman
Medical Times
|
November 1, 1973
How good is flexible fiberoptic bronchoscopy?
M Iseman
Drugs
|
March 24, 2000
Drug-resistant tuberculosis: what do we do now?
A Telenti, M Iseman
Annals of Internal Medicine
|
September 1, 1976
Letter: Preventing isoniazid hepatotoxicity
R Moulding, M Iseman, J Sbarbaro
Bulletin of the International Union Against Tuberculosis and Lung Disease
|
June 1, 1988
Application of rapid methods (BACTEC system) in clinical mycobacteriology and in the search for new drugs
L Heifets, M Iseman, P Lindholm-Levy
The American Review of Respiratory Disease
|
January 1, 1980
Long-term effectiveness of intermittent therapy for tuberculosis: final report of three Denver studies
J A Sbarbaro, B J Catlin, M Iseman
The Annals of Thoracic Surgery
|
November 1, 1991
Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections
M Pomerantz, L Madsen, M Goble, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1992
Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug Administration
P Hopewell, M Cynamon, J Starke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1992
Evaluation of new anti-infective drugs for the treatment and prevention of infections caused by the Mycobacterium avium complex. Infectious Diseases Society of America and the Food and Drug Administration
P Hopewell, M Cynamon, J Starke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1992
Evaluation of new anti-infective drugs for the treatment of disease caused by Mycobacterium kansasii and other mycobacteria. Infectious Diseases Society of America and the Food and Drug Administration
P Hopewell, M Cynamon, J Starke, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
JAMA
|
November 3, 2001
A 52-year-old man with a positive PPD
M Iseman
Medical Times
|
November 1, 1973
How good is flexible fiberoptic bronchoscopy?
M Iseman
Drugs
|
March 24, 2000
Drug-resistant tuberculosis: what do we do now?
A Telenti, M Iseman
Annals of Internal Medicine
|
September 1, 1976
Letter: Preventing isoniazid hepatotoxicity
R Moulding, M Iseman, J Sbarbaro
Bulletin of the International Union Against Tuberculosis and Lung Disease
|
June 1, 1988
Application of rapid methods (BACTEC system) in clinical mycobacteriology and in the search for new drugs
L Heifets, M Iseman, P Lindholm-Levy
The American Review of Respiratory Disease
|
January 1, 1980
Long-term effectiveness of intermittent therapy for tuberculosis: final report of three Denver studies
J A Sbarbaro, B J Catlin, M Iseman
The Annals of Thoracic Surgery
|
November 1, 1991
Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections
M Pomerantz, L Madsen, M Goble, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1992
Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug Administration
P Hopewell, M Cynamon, J Starke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1992
Evaluation of new anti-infective drugs for the treatment and prevention of infections caused by the Mycobacterium avium complex. Infectious Diseases Society of America and the Food and Drug Administration
P Hopewell, M Cynamon, J Starke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1992
Evaluation of new anti-infective drugs for the treatment of disease caused by Mycobacterium kansasii and other mycobacteria. Infectious Diseases Society of America and the Food and Drug Administration
P Hopewell, M Cynamon, J Starke, et al.
Page
of 2